Zorem 5 Capsule contains Ramipril 5 mg, an angiotensin-converting enzyme (ACE) inhibitor primarily indicated for the management of hypertension and heart failure. Ramipril acts by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation and reducing blood pressure. This mechanism also decreases aldosterone secretion, leading to reduced sodium and water retention, which helps alleviate the workload on the heart. Zorem 5 Capsule is commonly prescribed to reduce the risk of myocardial infarction, stroke, and cardiovascular mortality in patients at high risk. It is also beneficial in improving survival following myocardial infarction and in managing diabetic nephropathy by slowing the progression of kidney damage. The usual dosage should be individualized based on patient response and clinical condition, with monitoring of blood pressure, renal function, and serum electrolytes recommended during therapy. Common adverse effects include cough, dizziness, hypotension, and hyperkalemia. Use is contraindicated in patients with a history of angioedema related to previous ACE inhibitor therapy, pregnancy, and bilateral renal artery stenosis. Zorem 5 Capsule should be used under strict medical supervision to ensure efficacy and safety.